Data / Form D filings / CariCord, Inc.
CariCord, Inc.: Form D filings
CariCord, Inc., a biotechnology company in Aurora, CO, filed 5 Form D notices with the SEC between 2014 and 2018. The latest, on April 3, 2018, reports $289,609 sold of a $1.3 million offering to 2 investors.
Find out what CariCord, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 12635 E. Montview Blvd., Suite 142, Aurora, CO, 80045
- Phone
- (844) 227-4267
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2014
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1595518
The full lists. Form D filings in Colorado: 1,787 rows, $89.35, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 3, 2018 | New notice | $1,250,000 | $289,609 | $960,391 | 2 | Mar 21, 2018 | sec.gov |
| Oct 13, 2015 | New notice | $5,000,000 | $100,000 | $4,900,000 | 1 | Sep 25, 2015 | sec.gov |
| Jul 15, 2014 | New notice | $1,000,000 | $0 | $1,000,000 | 0 | Yet to occur | sec.gov |
| Apr 17, 2014 | Amendment | $500,000 | $450,000 | $50,000 | 18 | Dec 27, 2013 | sec.gov |
| Mar 27, 2014 | New notice | $500,000 | $450,000 | $50,000 | 18 | Dec 27, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Harry M. Kloor | Director | |
| Tate M. Hermanson | Director | |
| John Gabriel | Executive Officer, Director | |
| James Todd | Executive Officer | |
| Brian M. McEnroe | Director | |
| Gregory M. Andrews | Director | |
| Calvin Cole | Executive Officer, Director | |
| Brian M. Freed | Director |
Other biotechnology companies in Colorado that filed recently
- HealthVest Fund V LLC offering · Nov 5, 2026
- GelSana Therapeutics, Inc. $4.4 million · Oct 8, 2026
- Renovare Therapeutics, Inc. $100,000 · Oct 2, 2026
- EnteroTrack, LLC $2 million · Sep 25, 2026
Every Form D from the week of Apr 2, 2018 · All recent filings in Colorado · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what CariCord, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.